A new biotechnology start-up focused on the development of an universal Human Papillomavirus (HPV) vaccine to provide prophylaxis against all HPV-related cancers and diseases. Our pilot vaccine, RGVax, promises to provide protection against all 15 oncogenic HPVs and many others that cause various warts.
| Website | http://www.pathovax.com |
| Revenue | $1 million |
| Employees | 3 (0 on RocketReach) |
| Founded | 2014 |
| Address | 1812 Ashland Ave Ste 100, Baltimore, Maryland 21205, US |
| Phone | +1 443-449-8836 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Vaccines, Business Services, Science and Engineering, Human Papillomavirus, Clinical Trials, Health Care |
| Web Rank | 25 Million |
| Keywords | Vaccine Technology, Vaccine Research, Pharmaceutical Development, Drug Development, Immunotherapy, Clinical Trials, Biotechnology, Prevention, Prophylaxis |
| Competitors | Novavax, Moderna Therapeutics, Pfizer, AstraZeneca, Johnson & Johnson, Sanofi, Merck & Co., Inc., GSK, Regeneron, Roche +34 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular PathoVax LLC employee's phone or email?
PathoVax LLC Questions
The PathoVax LLC annual revenue was $1 million in 2026.
PathoVax LLC is based in Baltimore, Maryland.
The NAICS codes for PathoVax LLC are [5417, 54, 541713, 54171, 541].
The SIC codes for PathoVax LLC are [873, 87].
Related Companies
G2Crowd Trusted
300K+
Plugin Users
